Evidence map›Paper›PMID 34679659›Full record

ReviewAntioxidants (Basel, Switzerland)2021

The Natural Products Targeting on Allergic Rhinitis: From Traditional Medicine to Modern Drug Discovery.

Suhyun Lim, Iwah Jeong, Jonghyeok Cho, Chaewon Shin, Kwan-Il Kim, Bum-Sang Shim, Seong-Gyu Ko, Bonglee Kim

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Current issues in molecular biology · 2024
    Review
  9. Article
  10. Review
  11. Antiallergic Effects ofPlants (Basel, Switzerland) · 2023
    Article
  12. Soluble peptidoglycan fragments produced byFrontiers in molecular biosciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Suhyun LimCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Iwah JeongCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Jonghyeok ChoCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Chaewon ShinCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Kwan-Il KimDivision of Allergy, Immune and Respiratory System, Department of Internal Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-8071-3881
Bum-Sang ShimCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Seong-Gyu KoCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-2345-430X
Bonglee KimCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-8678-156X
Kyung Hee University · KR

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1I1A2066868)the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) No. 2020R1A5A2019413
6 · The paper itself

Abstract

More than 500 million people suffer from allergic rhinitis (AR) in the world. Current treatments include oral antihistamines and intranasal corticosteroids; however, they often cause side effects and are unsuitable for long-term exposure. Natural products could work as a feasible alternative, and this study aimed to review the efficacies and mechanisms of natural substances in AR therapies by examining previous literature. Fifty-seven studies were collected and classified into plants, fungi, and minerals decoction; clinical trials were organized separately. The majority of the natural products showed their efficacies by two mechanisms: anti-inflammation regulating diverse mediators and anti-oxidation controlling the activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway stimulated by reactive oxygen species (ROS). The main AR factors modified by natural products included interleukin (IL)-4, IL-5, IL-13, interferon-gamma (IFN-γ), tumor necrosis factor-α (TNF-α), cyclooxygenase 2 (COX-2), and phospho-ERK1/2 (p-ERK1/2). Although further studies are required to verify their efficacies and safeties, natural products can significantly contribute to the treatment of AR.

Indexed as

allergic rhinitisantioxidantsinflammationinterleukinnatural productsnuclear factor kappa-light-chain-enhancer of activated B cells

Identifiers

PMID34679659
PMCPMC8532887
OpenAlexW3204321585

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.